ADC Development

Antibody, drug, conjugate, conjugation, linker, novel technologies, adc, pharma, masterclass, drug design, development, adc

Pharmaceuticals/Drug Discovery, Medical & Health Care

Submit new post
Thank you for posting.
Share it:

SMi offer sponsorship, advertising and branding packages, uniquely tailored to compliment your company's marketing strategy.

Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry.

Paediatric drug development has become an essential part of drug development in general. A first paediatric pharmaceutical legislation came in force in the USA in 1997,

followed by the EU paediatric regulation in force since 2007. Without a Paediatric Investigation Plan (PIP) approved by the EMA paediatric committee, no new drug can be approved in the EU.

From: December 03, 2014 08:30
To: December 03, 2014 15:30

MSE Meeting Rooms - London, 103 Oxford St, London, United Kingdom


Pharmaceuticals/Drug Discovery, Medical & Health Care


antibody, conjugation, development, drug design




Submitted by:


Are you the organizer?

Get in touch